San Diego, California (September 10, 2019)/PRNewswire/ – Biosortia, a leader in the next frontier of drug discovery, accessing the enormous chemical and genomic potential of natural microbiomes, is pleased to announce the addition of leading metabolomics expert, Dr. John Ryals to the Board of Directors. “It is an honor to have Dr. Ryals join the Board